Krystal Biotech, Inc.KRYSNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
106.11%
↑ 756% above average
Average (36q)
12.39%
Historical baseline
Range
High:1700.00%
Low:-1341.65%
Volatility
24539.7%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 106.11% |
| Q2 2025 | 7.26% |
| Q1 2025 | -21.52% |
| Q4 2024 | 66.32% |
| Q3 2024 | 75.93% |
| Q2 2024 | 1700.00% |
| Q1 2024 | -90.32% |
| Q4 2023 | -89.24% |
| Q3 2023 | 330.40% |
| Q2 2023 | 28.98% |
| Q1 2023 | -40.80% |
| Q4 2022 | -6.84% |
| Q3 2022 | -6.36% |
| Q2 2022 | 44.72% |
| Q1 2022 | -103.06% |
| Q4 2021 | -40.00% |
| Q3 2021 | 5.41% |
| Q2 2021 | 0.00% |
| Q1 2021 | -42.31% |
| Q4 2020 | -6.12% |
| Q3 2020 | -32.43% |
| Q2 2020 | -19.35% |
| Q1 2020 | 0.00% |
| Q4 2019 | -24.00% |
| Q3 2019 | 32.43% |
| Q2 2019 | -27.59% |
| Q1 2019 | -7.41% |
| Q4 2018 | -3.85% |
| Q3 2018 | -18.18% |
| Q2 2018 | -4.76% |
| Q1 2018 | -50.00% |
| Q4 2017 | 88.89% |
| Q3 2017 | -1341.65% |
| Q2 2017 | 27.17% |
| Q1 2017 | 20.00% |
| Q4 2016 | -99.20% |
| Q3 2016 | 0.00% |